Literature DB >> 10498624

Molecular characterization of autosomal recessive chronic granulomatous disease caused by a defect of the nicotinamide adenine dinucleotide phosphate (reduced form) oxidase component p67-phox.

P J Patiño1, J Rae, D Noack, R Erickson, J Ding, D G de Olarte, J T Curnutte.   

Abstract

Chronic granulomatous disease (CGD) is a rare inherited disorder of phagocytes in which defective production of microbicidal oxidants leads to severe recurrent infections. CGD is caused by mutations in any of 4 genes encoding components of nicotinamide adenine dinucleotide phosphate (reduced form; NADPH) oxidase, the multisubunit enzyme that produces the precursor of these oxidants, superoxide. Approximately 5% of CGD patients have an autosomal recessive form of disease caused by a severe deficiency of p67-phox, a 526-amino acid subunit of the oxidase that appears to regulate electron transport within the enzyme. Here we report the biochemical and molecular characterization of 6 unrelated kindreds with p67-phox deficiency. These studies show that, as in gp91-phox and p22-phox deficiencies, the p67-phox CGD patients show a high degree of heterogeneity in the genetic defects that underlie their disease. Five different mutant alleles were identified: (1) a nonsense mutation in exon 4 (C(304) --> T); (2) a 5-nucleotide (nt) deletion in exon 13 (nts 1169-1173); (3) a splice mutation in the first nucleotide of intron 4 (G --> A); (4) a deletion of 1 nt in exon 9 (A(728)); and (5) a 9-nt in-frame deletion in exon 2 (nts 55-63). The splice mutation was seen in 3 unrelated kindreds, while the 5-nt deletion was seen in 2 apparently unrelated families (both of Palestinian origin). Homozygosity was present in 4 of the kindreds, 2 of which had consanguineous parentage. In the isolated neutrophils of each of the affected patients in the 6 kindreds, there was no measurable respiratory burst activity and no p67-phox protein detected by immunoblot analysis. The level of 67-phox mRNA was less than 10% of normal in the mononuclear leukocytes from 3 of the 4 patients analyzed by Northern blot studies. Thus, this heterogeneous group of mutations in p67-phox all lead to marked instability of mRNA or protein (or both) that results in the complete loss of NADPH oxidase activity.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10498624

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  13 in total

1.  Lupus-associated causal mutation in neutrophil cytosolic factor 2 (NCF2) brings unique insights to the structure and function of NADPH oxidase.

Authors:  Chaim O Jacob; Miriam Eisenstein; Mary C Dinauer; Wenyu Ming; Qiang Liu; Sutha John; Francesco P Quismorio; Andreas Reiff; Barry L Myones; Kenneth M Kaufman; Deborah McCurdy; John B Harley; Earl Silverman; Robert P Kimberly; Timothy J Vyse; Patrick M Gaffney; Kathy L Moser; Marisa Klein-Gitelman; Linda Wagner-Weiner; Carl D Langefeld; Don L Armstrong; Raphael Zidovetzki
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-27       Impact factor: 11.205

2.  Systemic lupus erythematosus-associated neutrophil cytosolic factor 2 mutation affects the structure of NADPH oxidase complex.

Authors:  Don L Armstrong; Miriam Eisenstein; Raphael Zidovetzki; Chaim O Jacob
Journal:  J Biol Chem       Date:  2015-03-20       Impact factor: 5.157

3.  Molecular basis of autosomal recessive chronic granulomatous disease in iran.

Authors:  Shahram Teimourian; Martin de Boer; Dirk Roos
Journal:  J Clin Immunol       Date:  2010-04-21       Impact factor: 8.317

4.  Allelic heterogeneity in NCF2 associated with systemic lupus erythematosus (SLE) susceptibility across four ethnic populations.

Authors:  Xana Kim-Howard; Celi Sun; Julio E Molineros; Amit K Maiti; Hema Chandru; Adam Adler; Graham B Wiley; Kenneth M Kaufman; Leah Kottyan; Joel M Guthridge; Astrid Rasmussen; Jennifer Kelly; Elena Sánchez; Prithvi Raj; Quan-Zhen Li; So-Young Bang; Hye-Soon Lee; Tae-Hwan Kim; Young Mo Kang; Chang-Hee Suh; Won Tae Chung; Yong-Beom Park; Jung-Yoon Choe; Seung Cheol Shim; Shin-Seok Lee; Bok-Ghee Han; Nancy J Olsen; David R Karp; Kathy Moser; Bernardo A Pons-Estel; Edward K Wakeland; Judith A James; John B Harley; Sang-Cheol Bae; Patrick M Gaffney; Marta Alarcón-Riquelme; Loren L Looger; Swapan K Nath
Journal:  Hum Mol Genet       Date:  2013-10-26       Impact factor: 6.150

5.  First report of clinical, functional, and molecular investigation of chronic granulomatous disease in nine Jordanian families.

Authors:  Faris G Bakri; Cécile Martel; Najwa Khuri-Bulos; Azmi Mahafzah; Mohammad S El-Khateeb; Adel M Al-Wahadneh; Wail A Hayajneh; Hanan A Hamamy; Elisabeth Maquet; Michelle Molin; Marie José Stasia
Journal:  J Clin Immunol       Date:  2008-09-05       Impact factor: 8.317

Review 6.  Hematologically important mutations: the autosomal recessive forms of chronic granulomatous disease (second update).

Authors:  Dirk Roos; Douglas B Kuhns; Anne Maddalena; Jacinta Bustamante; Caroline Kannengiesser; Martin de Boer; Karin van Leeuwen; M Yavuz Köker; Baruch Wolach; Joachim Roesler; Harry L Malech; Steven M Holland; John I Gallin; Marie-José Stasia
Journal:  Blood Cells Mol Dis       Date:  2010-02-18       Impact factor: 3.039

7.  Chronic Granulomatous Disease: A Large, Single-center US Experience.

Authors:  Pietro Bortoletto; Kyle Lyman; Andres Camacho; Marielle Fricchione; Aaruni Khanolkar; Ben Z Katz
Journal:  Pediatr Infect Dis J       Date:  2015-10       Impact factor: 2.129

Review 8.  Genetics and immunopathology of chronic granulomatous disease.

Authors:  Marie José Stasia; Xing Jun Li
Journal:  Semin Immunopathol       Date:  2008-05-29       Impact factor: 11.759

9.  Genetic, Immunological, and Clinical Features of the First Mexican Cohort of Patients with Chronic Granulomatous Disease.

Authors:  Lizbeth Blancas-Galicia; Eros Santos-Chávez; Caroline Deswarte; Quentin Mignac; Isabel Medina-Vera; Ximena León-Lara; Manon Roynard; Selma C Scheffler-Mendoza; Ricardo Rioja-Valencia; Alexandra Alvirde-Ayala; Saul O Lugo Reyes; Tamara Staines-Boone; Jorge García-Campos; Omar J Saucedo-Ramírez; Blanca E Del-Río Navarro; Antonio Zamora-Chávez; Arturo López-Larios; Susana García-Pavón-Osorio; Eugenia Melgoza-Arcos; María R Canseco-Raymundo; Dolores Mogica-Martínez; Marco Venancio-Hernández; Daniel Pacheco-Rosas; Sigifredo Pedraza-Sánchez; Martha Guevara-Cruz; Federico Saracho-Weber; Berenise Gámez-González; Guillermo Wakida-Kuzunoki; Ana R Morán-Mendoza; Ana P Macías-Robles; Roselia Ramírez-Rivera; Eugenia Vargas-Camaño; Carmen Zarate-Hernández; Héctor Gómez-Tello; Emmanuel Ramírez-Sánchez; Fredy Ruíz-Hernández; Domingo Ramos-López; Héctor Acuña-Martínez; María L García-Cruz; María G Román-Jiménez; Marina G González-Villarreal; Aristóteles Álvarez-Cardona; Beatriz A Llamas-Guillén; Jennifer Cuellar-Rodríguez; Alberto Olaya-Vargas; Nideshda Ramírez-Uribe; Stéphanie Boisson-Dupuis; Jean-Laurent Casanova; Francisco J Espinosa-Rosales; Jeanet Serafín-López; Marco Yamazaki-Nakashimada; Sara Espinosa-Padilla; Jacinta Bustamante
Journal:  J Clin Immunol       Date:  2020-02-10       Impact factor: 8.542

10.  Mimicking hypersensitivity pneumonitis as an uncommon initial presentation of chronic granulomatous disease in children.

Authors:  Hui Liu; Jinrong Liu; Huimin Li; Yun Peng; Shunying Zhao
Journal:  Orphanet J Rare Dis       Date:  2017-10-26       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.